BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18444877)

  • 1. Duration of stool colonization in patients infected with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Apisarnthanarak A; Bailey TC; Fraser VJ
    Clin Infect Dis; 2008 Apr; 46(8):1322-3. PubMed ID: 18444877
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epidemiological study on extended-spectrum beta-lactamase-producing in clinical isolates and selection of antibacterial drugs in China ].
    Yu YS
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1918-20. PubMed ID: 15631810
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term study of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Polwichai P; Trakulsomboon S; Dejsirilert S; Thongmali O; Sawanpanyalert P; Aswapokee N; Buppanharun W
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S53-8. PubMed ID: 21294502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.
    Shakil S; Ali SZ; Akram M; Ali SM; Khan AU
    J Trop Pediatr; 2010 Apr; 56(2):90-6. PubMed ID: 19608665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Labombardi VJ; Rojtman A; Tran K
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):313-5. PubMed ID: 17084784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections.
    Yang YS; Ku CH; Lin JC; Shang ST; Chiu CH; Yeh KM; Lin CC; Chang FY
    J Microbiol Immunol Infect; 2010 Jun; 43(3):194-9. PubMed ID: 21291846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Lee NY; Huang WH; Tsui KC; Hsueh PR; Ko WC
    Diagn Microbiol Infect Dis; 2011 May; 70(1):150-3. PubMed ID: 21398070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
    Koksal F; Ak K; Kucukbasmaci O; Samasti M
    Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of antimicrobial agents against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon.
    Samaha-Kfoury JN; Kanj SS; Araj GF
    Am J Infect Control; 2005 Apr; 33(3):134-6. PubMed ID: 15798666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures.
    de Cueto M; López L; Hernández JR; Morillo C; Pascual A
    Antimicrob Agents Chemother; 2006 Jan; 50(1):368-70. PubMed ID: 16377714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nosocomial infection due to ESBL-producing bacteria].
    Yagi T
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():90-4. PubMed ID: 12717952
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative in vitro activity of ertapenem against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated in Spain.
    Hernández JR; Velasco C; Romero L; Martínez-Martínez L; Pascual A
    Int J Antimicrob Agents; 2006 Nov; 28(5):457-9. PubMed ID: 17008066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nosocomial liver abscess caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
    Lin JC; Siu LK; Fung CP; Yeh KM; Chang FY
    J Clin Microbiol; 2007 Jan; 45(1):266-9. PubMed ID: 17093025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominance of CTX-M-15 extended spectrum beta-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait.
    Ensor VM; Jamal W; Rotimi VO; Evans JT; Hawkey PM
    Int J Antimicrob Agents; 2009 May; 33(5):487-9. PubMed ID: 19097760
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for and outcomes of healthcare-associated infection due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae in Thailand.
    Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
    Infect Control Hosp Epidemiol; 2007 Jul; 28(7):873-6. PubMed ID: 17564993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and outcome in extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bacteremia.
    Blot S; Memon JI
    Saudi Med J; 2009 Oct; 30(10):1366-7; author reply1366-7. PubMed ID: 19838454
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of extended spectrum beta-lactamases producing clinical isolates from patients of urinary tract infection in a tertiary care hospital in Delhi.
    Malhotra VL; Khandpur N; Dass A; Mehta G
    J Commun Dis; 2008 Dec; 40(4):269-72. PubMed ID: 19579719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.